Dataset Information

Ctla-4 gene polymorphism in +49 a/g position: a case control study on patients with oral lichen planus.

ABSTRACT: BACKGROUND:Oral lichen planus (OLP) is a premalignant mucocutaneous disease in which genetic factors and immune responses play a major role. Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) is a co-inhibitory molecule that down-regulates immune responses to prevent autoimmunity. This study aimed to investigate the relationship between polymorphism of the CTLA-4 gene in +49 A/G position and OLP. MATERIALS AND METHODS:Thirty-five patients with OLP (16 males, 19 females, with a mean age of [± standard deviation (SD)] 55.92 [± 12.83]) and 105 sex- and aged-matched healthy subjects (48 males, 57 females, with a mean age of [± SD] 56.82 [± 14.71]) were recruited in this study. Genomic DNA of both groups was extracted from white blood cells and then CTLA-4 genotypes and allele frequencies were investigated using polymerase chain reaction-restriction fragment length polymorphism methods. The data were collected and examined using Pearson's Chi square test (SPSS version 11.5). RESULTS:In the patient group, AA, AG, and GG genotypes occurred in position 49 A/G in the CTLA-4 gene with the frequency of 19 (55.9%), 11 (31.4%), and 3 (8.8%), respectively. With respect to the control group, they occurred with the frequency of 58 (55.2%), 39 (37.1%), and 8 (7.6%), respectively. As far as the frequency of A and G alleles in this position was concerned, we had, respectively, 49 (74.24%) and 17 (25.75%) for patients and, respectively, 155 (73.80%) and 55 (26.19%) for the control group. The calculated values were not significantly different between these groups (P > 0.05). CONCLUSION:Polymorphisms of CTLA-4 genes in position +49 A/G did not show any significant relationship with each other in OLP patients in Shiraz, Iran.

SUBMITTER: Ghapanchi J

PROVIDER: S-EPMC4229823 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Ctla-4 gene polymorphism in +49 a/g position: a case control study on patients with oral lichen planus.

Ghapanchi Jannan J Haghshenas Mohammad Reza MR Ghaderi Hamid H Amanpour Sara S Nemati Venus V Kamali Fereshteh F

Journal of international oral health : JIOH 20140901 5

<h4>Background</h4>Oral lichen planus (OLP) is a premalignant mucocutaneous disease in which genetic factors and immune responses play a major role. Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) is a co-inhibitory molecule that down-regulates immune responses to prevent autoimmunity. This study aimed to investigate the relationship between polymorphism of the CTLA-4 gene in +49 A/G position and OLP.<h4>Materials and methods</h4>Thirty-five patients with OLP (16 males, 19 females, with a mean age of ...[more]

PMID: 25395787

Similar Datasets

Project description:BackgroundA growing number of studies has investigated IL-17 in OLP. However, its exact role and interactions are not fully determined. In addition, the literature investigating its salivary expression is limited. The scarcity in the literature studying lncRNAs was noticed, particularly with regards to correlating them with cytokines in OLP. In the current study, the salivary expression of lncRNA DQ786243 and IL-17 was assessed among different forms of OLP.MethodsThe study included 52 participants in four equal groups: reticular OLP, erythematous OLP, ulcerative OLP, and control group. All eligible OLP patients underwent conventional oral examination, along with basic charting of their demographic data, pain intensity using a visual analogue scale, and clinical evaluation using the Thongprasom et al. scale. The salivary expression of lncRNA DQ786243 and IL-17 was evaluated for all participants using qRT-PCR. Unstimulated whole saliva samples were used. Data were analyzed for statistical significance.ResultsNo statistically significant difference was observed when comparing the mean age and gender distribution of the studied groups. A statistically significant difference was detected when comparing pain and clinical scores in the three OLP forms. The highest expression of both salivary biomarkers was noticed in ulcerative OLP, followed by erythematous OLP and reticular OLP, then the controls, with a significant difference between the studied groups. Upon comparing the salivary expression of DQ786243 in ulcerative and erythematous OLP, no significant difference was detected. No significant difference was detected when comparing salivary expression of IL-17 in erythematous OLP to the other OLP forms.ConclusionsThe salivary expression of lncRNA DQ786243 and IL-17 was upregulated in OLP compared to healthy individuals. Besides, their expression increased when the severity of OLP was at its highest level in ulcerative OLP. There was a positive correlation between DQ786243 and IL-17. Trial registration The protocol was registered at ClinicalTrials.gov (NCT04503824). The date of registration is 07/08/2020.

Dataset Information

Ctla-4 gene polymorphism in +49 a/g position: a case control study on patients with oral lichen planus.

Publications

Ctla-4 gene polymorphism in +49 a/g position: a case control study on patients with oral lichen planus.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets